MedPath

COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic

Completed
Conditions
Bronchiectasis
Covid19
Registration Number
NCT04487873
Lead Sponsor
Hacettepe University
Brief Summary

In the literature, there are no studies evaluating COVID-19 phobia, quality of life, health anxiety, physical activity level and quality of sleep in patients with bronchiectasis during COVID-19 pandemic. The investigators will evaluate these parameters in patients with bronchiectasis and compare the findings of healthy individuals during COVID-19 pandemic

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
74
Inclusion Criteria
  • Having been diagnosed with non-cystic fibrosis bronchiectasis
  • No acute bronchiectasis exacerbation or infection in the past 2 weeks
  • Volunteering to participate in the research
Read More
Exclusion Criteria
  • Having a cognitive problem
  • Not being literate
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
COVID-19 Phobia5 minutes

COVID-19 phobia was evaluated with COVID-19 Phobia Scale (C19P-S) and total score ranges from 20-100. Lower scores mean better outcome.

Qol10 minutes

Quality of life was evaluated with Nottingham Health Profile

Secondary Outcome Measures
NameTimeMethod
Physical activity5 minutes

Physical activity level was evaluated with International Physical Activity Questionnaire - Short Form (IPAQ-SF)

Health anxiety10 minutes

Health anxiety was evaluated with Health Anxiety Inventory

Quality of sleep10 minutes

Quality of sleep was evaluated with Pittsburgh Sleep Quality Index

Trial Locations

Locations (1)

Hacettepe University, Faculty of Physical Therapy and Rehabilitation

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath